115 related articles for article (PubMed ID: 834187)
1. High molecular weight derivatives of methotrexate as chemotherapeutic agents.
Chu BC; Whiteley JM
Mol Pharmacol; 1977 Jan; 13(1):80-8. PubMed ID: 834187
[No Abstract] [Full Text] [Related]
2. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
Sirotnak FM; Donsbach RC
Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
[No Abstract] [Full Text] [Related]
3. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
4. Analysis of tests of chemotherapeutic agents involving repeated drug treatment.
Ullman NS; Jacquez JA
Biometrics; 1973 Dec; 29(4):677-93. PubMed ID: 4785233
[No Abstract] [Full Text] [Related]
5. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
Goncharova SA; Frankfurt OS
Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
Yancey ST; Bleyer WA
Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
[No Abstract] [Full Text] [Related]
7. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
[No Abstract] [Full Text] [Related]
8. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
Zager RF; Frisby SA; Oliverio VT
Cancer Res; 1973 Jul; 33(7):1670-6. PubMed ID: 4124487
[No Abstract] [Full Text] [Related]
9. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
Semon JH; Grindey GB
Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
[No Abstract] [Full Text] [Related]
12. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.
Auletta AE; Gery AM; Mead JA
Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911
[No Abstract] [Full Text] [Related]
13. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
14. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
15. Effects of allopurinol on the therapeutic efficacy of methotrexate.
Grindey GB; Moran RG
Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
[No Abstract] [Full Text] [Related]
17. Alpha-monoamides of methotrexate as potential prodrugs.
Antonjuk DJ; Boadle DK; Cheung HT; Friedlander ML; Gregory PM; Tattersall MH
Arzneimittelforschung; 1989 Jan; 39(1):12-5. PubMed ID: 2719739
[TBL] [Abstract][Full Text] [Related]
18. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
Sirotnak FM; Donsbach RC
Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
[No Abstract] [Full Text] [Related]
19. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
Bruckner HW; Schreiber C; Waxman S
Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
Chang BK; Huang AT; Joines WT
Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
